Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$16M
6 rounds on record
Latest round
$3.6M
Venture round · Jul 2025 · 15 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
15 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Jul 1, 2025 Raised a round Venture round $3.6M · SEC Form D Jan 17, 2024 Raised a round Venture round $2.1M · SEC Form D 2022 Founded Sep 30, 2021 Raised a round Venture round $7.9M · SEC Form D Feb 15, 2019 Raised a round Venture round $1.9M · SEC Form D Dec 12, 2016 Raised a round Venture round $623k · SEC Form D Aug 14, 2013 Took on debt financing $50k · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Jul 2025 $3.6M — SEC Form D
Venture round Jan 2024 $2.1M — SEC Form D
Venture round Sep 2021 $7.9M — SEC Form D
Venture round Feb 2019 $1.9M — SEC Form D
Venture round Dec 2016 $623k — SEC Form D
Debt Financing Aug 2013 $50k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity KromaTiD, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
James ChomasExecutive Officer, DirectorSEC Form D
Andrew JostExecutive OfficerSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Applied CellsFounded 2018 • 11-50 employees
Supporting industry experts in cell therapy development and tumor detection. Discover our column-free cell isolation MARS platforms.
GeneVentiv TherapeuticsVenture round $1.4M · 4 yr ago • Founded 2020 • 11-50 employees
GeneVentiv Therapeutics — advancing gene therapy approaches.
TECHNOLOGY M20 Seq Single-Cell Transcriptome M20 Spatial Spatial Transcriptome PRODUCTS Single-Cell Transcriptome for FFPE Samples…
PrognosVenture round $23.3M · 3 yr ago • 51-200 employees
Unlock actionable clinical and genomic laboratory data with Prognos Health, enhancing patient outcomes and accelerating commercial…
WhiteLab GenomicsSeries B $26M · this month • Founded 2019 • 11-50 employees
Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for…
Skyline Therapeutics is a fully integrated gene therapy company dedicated to the discovery, development and delivery of innovative…

Overview

KROMATID delivers high-quality genomic integrity data through single-cell analysis, enhancing safety and efficacy in cell and gene therapy development for better patient outcomes.

People

James Chomas
Executive Officer, Director
Andrew Jost
Executive Officer
Walter Young
Director
Priyadarshini Gogoi
Director
Jack Ball
Director
Terry Opgenorth
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
2
Hiring now
0
Countries
1
Loading the map
Headquarters Builds here Office with open vacancies No open vacancies right now Tap a pin for the office
Longmont United States
HQ
Boulder United States
Regional office
Get in Touch Today to Talk to an Expert!
6899 Winchester Cir, Ste 100, Boulder, CO 80301
company site

Financials

Total raised
$16.1M
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $3.6M Details
Venture - Series Unknown 2024 $2.1M Details
Venture - Series Unknown 2021 $7.9M Details
Venture - Series Unknown 2019 $1.9M Details
Venture - Series Unknown 2016 $623k Details
Debt Financing 2013 $50k Details